ME
MEDS (MEDS)
$2.02
—
Mkt Cap —
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$241.50
Range $163.80 – $283.50
Implied Upside
+11855.4%
Consensus $241.50 vs current $2.02
$2.02
—
Mkt Cap —
No recent rating data.
Price Target (28 analysts)
$241.50
Range $163.80 – $283.50
+11855.4%
Consensus $241.50 vs current $2.02